BIOXYTRAN, INC Cash Flow Statement
BIXT|7 years of annual SEC 10-K data (FY2011-FY2017)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$18,518
FY2017
Free Cash Flow
N/A
FY2017
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2017
BIOXYTRAN, INC used $18,518 in operating cash flow in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -7713.38 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Net Income | -$318.4K | -$696.8K | -$2.1M | -$1.3M | -$1.8M | -$2.3M | -$4.4M |
| Operating Cash Flow | -$18.5K | -$42.4K | -$2.7K | -$16.3K | $9.3K | -$63.7K | -$398.8K |